AEMD Aethlon Medical, Inc.
$1.53▼ -1.92%
Healthcare
Other
After hours
$1.55▲ +1.31%
Sep 11, 7:59 PM ET
Volume 103.0K
Avg Volume (10D) 4.77M
Key Metrics & Fundamentals
Market Cap
$1.09M
P/E Ratio
–
Div Yield
–%
52W Range
1.52 - 41.50
% vs 50 MA
-45.83%
% vs 200 MA
-84.08%
RSI-14
25.4
MACD Histogram
-0.0100
Beta (1Y vs SPY)
2.11
Free Cash Flow
-$1.75M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.69M
COGS
–
Operating Exp
$1.93M
Operating Income
-$1.93M
EBIT
-$1.93M
Pretax Income
-$1.88M
Net Income
-$1.88M
Price & Volume History
Loading chart…
Recent News
AEMD: Oncology Study Advances; Cost-Efficient Preclinical Activities Regarding Other Diseases Continue
Zacks Small Cap Research · Aug 19, 2026 10:36 AM
Presenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live stream
GlobeNewswire · Aug 18, 2026 11:00 AM
Aethlon Medical, Inc. Q1 2027 Earnings Call Summary
Moby · Aug 14, 2026 12:30 PM
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
PR Newswire · Aug 13, 2026 8:15 PM
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
PR Newswire · Aug 5, 2026 12:01 PM
Presenting on Emerging Growth Conference 94 Day 2 on July 16; Register to live stream
GlobeNewswire · Jul 15, 2026 11:00 AM
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®
PR Newswire · Jul 13, 2026 12:01 PM
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
PR Newswire · Jul 6, 2026 1:25 PM
Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®
PR Newswire · Jun 26, 2026 12:01 PM
Aethlon Medical advances Hemopurifier study as final trial cohort nears completion
Proactive · Jun 17, 2026 4:18 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See AEMD's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.